No significant difference in the risk for MACE was observed between patients with IBD receiving JAK vs TNF inhibitors.

Higher FT4 levels were associated with increased risks for knee OA prevalence, severity, and progression, especially among patients with greater joint loading.

Increased postoperative opioid consumption was associated with higher probability of new persistent opioid use in opioid-naive patients.

Among children with high blood pressure (BP), there are racial and ethnic disparities in receipt of nutrition, lifestyle, and weight counseling.

Observational data fill a knowledge gap in the absence of randomized trials comparing empagliflozin vs dapagliflozin in patients with type 2 diabetes.

Compared with thrombotic stroke, hemorrhagic stroke has more than double the odds of diagnostic delay in pregnant and postpartum patients.

Using glucocorticoids, rituzimab, or certain immunosuppressants to treat connective tissue diseases is associated with greater risks for severe COVID-19-related outcomes.

Male patients with inflammatory bowel disease (IBD) face a higher risk for ischemic heart diseases (IHDs), according to a study.

Patients with diabetic DED can experience inflammatory biomarker reductions and sign and symptom improvements with topical insulin.

On February 7, the NIH announced that it would begin capping indirect cost payments for new and existing research grants at 15%.

Older age, lower education, and living in a rural area are associated with physical inactivity among stroke survivors.

The FDA has accepted for review the BLA for lerodalcibep to reduce LDL-C in patients with or high risk of ASCVD and primary hyperlipidemia.